Background: Clostridium difficile infection (CDI) is a frequent complication in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), who receive intensive treatments that significantly disrupt the intestinal microbiota. In this study, we examined the microbiota composition of allo-HSCT recipients to identify bacterial colonizers that confer protection against CDI after engraftment. Methods: Feces collected from adult recipients allo-HSCT at engraftment were analyzed; 16S ribosomal RNA genes were sequenced and analyzed from each sample. Bacterial taxa with protective effects against development of CDI were identified by means of linear discriminant analysis effect size analysis and then further assessed with clinical predictors of CDI using survival analysis. Results: A total of 234 allo-HSCT recipients were studied; postengraftment CDI developed in 53 (22.6%). Within the composition of the microbiota, the presence of 3 distinct bacterial taxa was correlated with protection against CDI: Bacteroidetes, Lachnospiraceae, and Ruminococcaceae. Colonization with these groups at engraftment was associated with a 60% lower risk of CDI, independent of clinical factors. Conclusions: Colonization with these 3 bacterial groups is associated with a lower risk of CDI. These groups have been shown to be vital components of the intestinal microbiota. Targeted efforts to maintain them may help minimize the risk of CDI in this at-risk population. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Clostridium difficileinfection (CDI) is a frequent complication in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), who receive intensive treatments that significantly disrupt the intestinal microbiota. In this study, we examined the microbiota composition of allo-HSCT recipients to identify bacterial colonizers that confer protection against CDI after engraftment. Methods: Feces collected from adult recipients allo-HSCT at engraftment were analyzed; 16S ribosomal RNA genes were sequenced and analyzed from each sample. Bacterial taxa with protective effects against development of CDI were identified by means of linear discriminant analysis effect size analysis and then further assessed with clinical predictors of CDI using survival analysis. Results: A total of 234 allo-HSCT recipients were studied; postengraftment CDI developed in 53 (22.6%). Within the composition of the microbiota, the presence of 3 distinct bacterial taxa was correlated with protection against CDI: Bacteroidetes, Lachnospiraceae, and Ruminococcaceae. Colonization with these groups at engraftment was associated with a 60% lower risk of CDI, independent of clinical factors. Conclusions: Colonization with these 3 bacterial groups is associated with a lower risk of CDI. These groups have been shown to be vital components of the intestinal microbiota. Targeted efforts to maintain them may help minimize the risk of CDI in this at-risk population. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Robert R Jenq; Ying Taur; Sean M Devlin; Doris M Ponce; Jenna D Goldberg; Katya F Ahr; Eric R Littmann; Lilan Ling; Asia C Gobourne; Liza C Miller; Melissa D Docampo; Jonathan U Peled; Nicholas Arpaia; Justin R Cross; Tatanisha K Peets; Melissa A Lumish; Yusuke Shono; Jarrod A Dudakov; Hendrik Poeck; Alan M Hanash; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Eric G Pamer; Marcel R M van den Brink Journal: Biol Blood Marrow Transplant Date: 2015-05-11 Impact factor: 5.742
Authors: M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow Journal: Int J Syst Bacteriol Date: 1994-10
Authors: Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer Journal: Nature Date: 2014-10-22 Impact factor: 49.962
Authors: Jason Zou; Victor Leung; Sylvie Champagne; Michelle Hinch; Anna Wong; Elisa Lloyd-Smith; Trong Tien Nguyen; Marc G Romney; Azra Sharma; Michael Payne; Christopher F Lowe Journal: Eur J Clin Microbiol Infect Dis Date: 2018-09-20 Impact factor: 3.267
Authors: Rafael Araos; Nikolaos Andreatos; Juan Ugalde; Susan Mitchell; Eleftherios Mylonakis; Erika M C D'Agata Journal: Dig Dis Sci Date: 2018-03-28 Impact factor: 3.199
Authors: Ying Taur; Katharine Coyte; Jonas Schluter; Elizabeth Robilotti; Cesar Figueroa; Mergim Gjonbalaj; Eric R Littmann; Lilan Ling; Liza Miller; Yangtsho Gyaltshen; Emily Fontana; Sejal Morjaria; Boglarka Gyurkocza; Miguel-Angel Perales; Hugo Castro-Malaspina; Roni Tamari; Doris Ponce; Guenther Koehne; Juliet Barker; Ann Jakubowski; Esperanza Papadopoulos; Parastoo Dahi; Craig Sauter; Brian Shaffer; James W Young; Jonathan Peled; Richard C Meagher; Robert R Jenq; Marcel R M van den Brink; Sergio A Giralt; Eric G Pamer; Joao B Xavier Journal: Sci Transl Med Date: 2018-09-26 Impact factor: 17.956
Authors: James W Keith; Qiwen Dong; Matthew T Sorbara; Simone Becattini; Jonathan K Sia; Mergim Gjonbalaj; Ruth Seok; Ingrid M Leiner; Eric R Littmann; Eric G Pamer Journal: Infect Immun Date: 2020-03-23 Impact factor: 3.441
Authors: Igor Stoma; Eric R Littmann; Jonathan U Peled; Sergio Giralt; Marcel R M van den Brink; Eric G Pamer; Ying Taur Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079